These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2389428)
1. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Morris RE; Hoyt EG; Murphy MP; Eugui EM; Allison AC Transplant Proc; 1990 Aug; 22(4):1659-62. PubMed ID: 2389428 [No Abstract] [Full Text] [Related]
2. Comparison of the immunosuppressive effects of mycophenolic acid and the morpholinoethyl ester of mycophenolic acid (RS-61443) in recipients of heart allografts. Morris RE; Wang J Transplant Proc; 1991 Feb; 23(1 Pt 1):493-6. PubMed ID: 1990597 [No Abstract] [Full Text] [Related]
3. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467 [No Abstract] [Full Text] [Related]
4. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection. Morris RE; Wu J; Shorthouse R Transplant Proc; 1990 Aug; 22(4):1638-41. PubMed ID: 1697111 [No Abstract] [Full Text] [Related]
5. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Allison AC; Eugui EM Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053 [TBL] [Abstract][Full Text] [Related]
6. Bromocriptine plus suboptimal cyclosporine treatment abrogates acute rejection of rat cardiac allografts. Di Stefano R; Carmellini M; Carobbi A; Vaglini F; Petrini M; Ricci F; Mosca F; Malvaldi G Transplant Proc; 1990 Aug; 22(4):2015-6. PubMed ID: 2389514 [No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model. Klupp J; van Gelder T; Dambrin C; Regieli J; Boeke K; Billingham ME; Morris RE Transplant Proc; 2001 May; 33(3):2170-1. PubMed ID: 11377490 [No Abstract] [Full Text] [Related]
9. 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo. Yuh DD; Morris RE Transplant Proc; 1991 Feb; 23(1 Pt 1):535-9. PubMed ID: 1990605 [No Abstract] [Full Text] [Related]
10. Efficacy of rapamycin, RS-61443, and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts. Yatscoff RW; Wang S; Keenan R; Chackowsky P; Koshal A Transplant Proc; 1994 Jun; 26(3):1271-3. PubMed ID: 8029905 [No Abstract] [Full Text] [Related]
12. The influence of RS-61443 on antibody-mediated rejection. Knechtle SJ; Wang J; Burlingham WJ; Beeskau M; Subramanian R; Sollinger HW Transplantation; 1992 Mar; 53(3):699-701. PubMed ID: 1549873 [No Abstract] [Full Text] [Related]
13. Heterotopic rat intestinal transplantation: effect of cyclosporine and RS-61443 on graft-vs-host disease and rejection. D'Alessandro AM; Rankin MA Transplant Proc; 1994 Jun; 26(3):1611-2. PubMed ID: 8030056 [No Abstract] [Full Text] [Related]
14. Prolongation of dog renal allograft survival by RS-61443, a new, potent immunosuppressive agent. Platz KP; Eckhoff DE; Hullett DA; Sollinger HW Transplant Proc; 1991 Feb; 23(1 Pt 1):497-8. PubMed ID: 1990598 [No Abstract] [Full Text] [Related]
15. [Initial experience with mycophenolate mofetil (RS 61443) after kidney transplantation]. Friedrich J; Erhard J Zentralbl Chir; 1994; 119(1):48-9. PubMed ID: 8147160 [No Abstract] [Full Text] [Related]
16. Enhancement of allograft survival by combination RS-61443 and DUP-785 therapy. Kawamura T; Hullett DA; Suzuki Y; Bechstein WO; Allison AM; Sollinger HW Transplantation; 1993 Apr; 55(4):691-4; discussion 694-5. PubMed ID: 8475537 [TBL] [Abstract][Full Text] [Related]
17. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival. Wang J; Morris RE Transplant Proc; 1991 Feb; 23(1 Pt 1):699-702. PubMed ID: 1990655 [No Abstract] [Full Text] [Related]
18. Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785). Hullett DA; Kawamura T; Fujino Y; Allison AM; Sollinger HW Transplant Proc; 1993 Feb; 25(1 Pt 1):700-1. PubMed ID: 8438444 [No Abstract] [Full Text] [Related]